Skip to content
Menu

Ocular Therapeutix, Inc. OCUL

Full chart Compare
Set alert

Price alert · OCUL

All alert types
5.57 USD -0.29 (-4.95%)

Regular-session close

5.63 +0.06 +1.08%

After hours · Nov 20, 4:07 PM ET

5.54 Day range 5.95
5.54 52-week range 16.44
YTD
-54.12%
1 year
-52.47%

Revenue & Expenses

Revenue by
Revenue Profit Costs
Other Income$4.21MGross Profit$45.25MNet Loss$265.94MCost of Revenue$6.57MExpenses$315.39MSelling, General & Admin$118.30MResearch & Development$197.10MRevenue$51.82MProduct$51.82MCollaboration revenue$128.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

OCUL annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
51.95M63.72M58.44M51.49M43.52M
45.38M58.10M53.16M46.95M39.12M
-270.02M-171.78M-82.38M-78.65M-78.04M
-265.94M-193.51M-80.74M-71.04M-6.55M
-1.42-1.22-1.02-0.97-0.98
OCUL annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
738.67M393.72M197.57M104.06M165.93M
808.06M457.94M252.06M149.29M204.89M
153.75M142.59M160.93M113.91M116.89M
76.97M75.78M83.39M64.28M58.98M
654.31M315.34M91.13M35.38M88.00M
OCUL annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-204.88M-134.68M-70.23M-59.60M-65.55M
-11.88M-1.29M-6.09M-3.71M-1.19M
561.72M332.11M169.83M1.45M2.85M
-11.88M-1.29M-6.09M-3.71M-1.19M
344.96M196.15M93.51M-61.86M-63.89M